ANGELO DAVIS: Open Payments
NPI 1356107569 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 40 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $250 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $234 |
| Otsuka America Pharmaceutical, Inc. | 7 | $206 |
| Axsome Therapeutics, Inc. | 4 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| JAZZ PHARMACEUTICALS INC. | 1 | $70 |
| Supernus Pharmaceuticals, Inc. | 1 | $70 |
| Janssen Pharmaceuticals, Inc | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: COBENFY, Auvelity, REXULTI, CAPLYTA, XYWAV, Qelbree, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across NE — which companies pay providers there.
